Table 1 n = 50
| Â | Â | Clinical response | Clinical no response | Immuno-histochemical response | Immuno-histochemical no response |
|---|---|---|---|---|---|
Mean age | 45.5 years | Â | Â | Â | Â |
Range | 28–71 yrs |  |  |  |  |
Menopausal status | Â | Â | Â | Â | Â |
Pre-menopausal | 53.3% | 62.5% | 37.5% | 56.2% | 43.8% |
Post-menopausal | 46.7% | 71.4% | 28.6% | 64.2% | 35.8% |
Tumor size | Â | Â | Â | Â | Â |
<5 cm | 0% | - | - | - | - |
5–8 cm | 56.6% | 68.7% | 31.3% | 60% | 40% |
8–10 cm | 26.6% | 75% | 25% | 60% | 40% |
>10 cm | 16.6% | 66.6% | 33.3% | 60% | 40% |
Axillary lymph nodes | Â | Â | Â | Â | Â |
N0 | 0% | - | - | - | - |
N1 | 33% | 29.4%(toN0) | 70.6% | 60% | 40% |
N2 | 67% | 7.7%(N0), 46.2%(N1) | 46.2% | 60% | 40% |
Total | Â | 70% (p < 0.0001) | 30% | 60%(p = 0.008) | 40% |